Pharma Sector Updates

Economics of innovation is not understood in India: Biocon Bio-tech queen Kiran Mazumdar-Shaw spills the beans on CNBC-TV18’s Forbes India Show about her past, present and future.    

Lupin gets greedy, expects 14-15 launches this year
With a string of news coming from drug firm Lupin, the     

... Natco to partner Lupin to market generic breast cancer drug
Hyderabad-based Natco Pharma has filed an abbreviated n...    

 No impact on margin until share price halves: Orchid Chem
K Raghavendra Rao, MD of Orchid Chemicals & Pharmaceuti..    

. Sun Pharma gets US FDA nod for migraine treatment injection
A subsidiary of Sun Pharmaceutical Industries has recei.   

.. Glenmark gets USFDA nod for Norgestimate, Ethinyl Estradiol
Glenmark Generics USA has got final approval from US Fo..      

. Revenues of Indian biotech sector surge to $4 bn in 2010-11
The Indian biotech and lifesciences industry recorded t..    

. Max India to buy Warburg Pincus' stake in Max Healthcare
Max India’s board has approved the acquisition of 16.37...    

 JB Chemicals eyes OTC business deal closure around July 15
Pranabh Mody, President of JB Chemicals & Pharmaceutica.     

.. Dishman Pharma eyes 15% topline, bottomline growth in FY12
In an interview with CNBC-TV18, VVS Murthy, CFO, Dishma...